Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1988 Mar;51(3):436–439. doi: 10.1136/jnnp.51.3.436

Abnormalities of autonomic function in the Lambert Eaton myasthenic syndrome.

J P Heath 1, D J Ewing 1, R E Cull 1
PMCID: PMC1032876  PMID: 3361337

Abstract

Two cases of Lambert Eaton syndrome unassociated with an underlying malignancy are described. Both had mild autonomic symptoms but markedly abnormal autonomic function tests. These results are suggestive of a widespread defect in cholinergic transmission in addition to that at the skeletal neuromuscular junction.

Full text

PDF
436

Images in this article

437Image
on p.437

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahmed M. N., Carpenter S. Autonomic neuropathy and carcinoma of the lung. Can Med Assoc J. 1975 Sep 6;113(5):410–412. [PMC free article] [PubMed] [Google Scholar]
  2. EATON L. M., LAMBERT E. H. Electromyography and electric stimulation of nerves in diseases of motor unit; observations on myasthenic syndrome associated with malignant tumors. J Am Med Assoc. 1957 Mar 30;163(13):1117–1124. doi: 10.1001/jama.1957.02970480021005. [DOI] [PubMed] [Google Scholar]
  3. Elmqvist D., Lambert E. H. Detailed analysis of neuromuscular transmission in a patient with the myasthenic syndrome sometimes associated with bronchogenic carcinoma. Mayo Clin Proc. 1968 Oct;43(10):689–713. [PubMed] [Google Scholar]
  4. Gould G. A., Ashworth M., Lewis G. T. Are cardiovascular reflexes more commonly impaired in patients with bronchial carcinoma? Thorax. 1986 May;41(5):372–375. doi: 10.1136/thx.41.5.372. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hawley R. J., Cohen M. H., Saini N., Armbrustmacher V. W. The carcinomatous neuromyopathy of oat cell lung cancer. Ann Neurol. 1980 Jan;7(1):65–72. doi: 10.1002/ana.410070112. [DOI] [PubMed] [Google Scholar]
  6. Lambert E. H. Defects of neuromuscular transmission in syndromes other than myasthenia gravis. Ann N Y Acad Sci. 1966 Jan 26;135(1):367–384. doi: 10.1111/j.1749-6632.1966.tb45484.x. [DOI] [PubMed] [Google Scholar]
  7. Lambert E. H., Lennon V. A. Neuromuscular transmission in nude mice bearing oat cell tumors from Lambert-Eaton myasthenic syndrome. Muscle Nerve. 1982;5(9S):S39–S45. [PubMed] [Google Scholar]
  8. Lang B., Newsom-Davis J., Wray D., Vincent A., Murray N. Autoimmune aetiology for myasthenic (Eaton-Lambert) syndrome. Lancet. 1981 Aug 1;2(8240):224–226. doi: 10.1016/s0140-6736(81)90474-8. [DOI] [PubMed] [Google Scholar]
  9. Lennon V. A., Lambert E. H., Whittingham S., Fairbanks V. Autoimmunity in the Lambert-Eaton myasthenic syndrome. Muscle Nerve. 1982;5(9S):S21–S25. [PubMed] [Google Scholar]
  10. Lundh H., Nilsson O., Rosén I. Treatment of Lambert-Eaton syndrome: 3,4-diaminopyridine and pyridostigmine. Neurology. 1984 Oct;34(10):1324–1330. doi: 10.1212/wnl.34.10.1324. [DOI] [PubMed] [Google Scholar]
  11. Mamdani M. B., Walsh R. L., Rubino F. A., Brannegan R. T., Hwang M. H. Autonomic dysfunction and Eaton Lambert syndrome. J Auton Nerv Syst. 1985 Apr;12(4):315–320. doi: 10.1016/0165-1838(85)90046-3. [DOI] [PubMed] [Google Scholar]
  12. Newsom-Davis J., Murray N. M. Plasma exchange and immunosuppressive drug treatment in the Lambert-Eaton myasthenic syndrome. Neurology. 1984 Apr;34(4):480–485. doi: 10.1212/wnl.34.4.480. [DOI] [PubMed] [Google Scholar]
  13. Roberts A., Perera S., Lang B., Vincent A., Newsom-Davis J. Paraneoplastic myasthenic syndrome IgG inhibits 45Ca2+ flux in a human small cell carcinoma line. Nature. 1985 Oct 24;317(6039):737–739. doi: 10.1038/317737a0. [DOI] [PubMed] [Google Scholar]
  14. Rubenstein A. E., Horowitz S. H., Bender A. N. Cholinergic dysautonomia and Eaton-Lambert syndrome. Neurology. 1979 May;29(5):720–723. doi: 10.1212/wnl.29.5.720. [DOI] [PubMed] [Google Scholar]
  15. Willcox N., Demaine A. G., Newsom-Davis J., Welsh K. I., Robb S. A., Spiro S. G. Increased frequency of IgG heavy chain marker Glm(2) and of HLA-B8 in Lambert-Eaton myasthenic syndrome with and without associated lung carcinoma. Hum Immunol. 1985 Sep;14(1):29–36. doi: 10.1016/0198-8859(85)90062-x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES